Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer.

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-22-684/coif). AGK receives support from the National Heart, Lung, and Blood Institute of the National Institutes of Health T35 (No. HL007485). AMP receives grant funding from and is a consultant for Boston Scientific. She also is a consultant for Endo Pharmaceuticals and she is on the medical advisory board for FirmTech. After the conclusion of data collection but prior to publication, AMP co-founded the PRIME institute, a for-profit company. EET has received salary support provided by NIH (No. NIH R00AR071508) and Institutional NIH support for core resources (No. NIH P30CA086862). She has also received grants from NIH (No. NIH R21 CA257972), lecture honoraria from the University of Kentucky and West Virginia University, travel costs for AACR Annual Meeting 2023 (Invited Speaker) from the American Association for Cancer Research, travel costs for the seminar from West Virginia University, Travel costs for 18th International Biochemistry of Exercise Conference (Invited Speaker) from International Research Group on Biochemistry of Exercise, and travel costs for Journées de la Société Française de Myologie (Invited Speaker) from Société Française de Myologie. EET was also the Co-chair of the education committee of Cancer Cachexia Society. The other authors have no conflicts of interest to declare."

"Funding: This study was supported by the Biospecimen Procurement and Molecular Epidemiology Resource (BioMER) and the Biostatistics Core of the Holden Comprehensive Cancer Center through funds from the National Cancer Institute of the National Institutes of Health ( No. P30CA086862 ). Additional University of Iowa funds were used to support research costs, and a portion of EET’s salary was supported by National Institutes of Health ( No. R00AR071508 ). This study was also supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health T35 ( No. HL007485 to AGK)."